How Transformative Trends In Bone Metastasis Therapeutics Market Are Molding Strategies Of Consumers?

19/feb/2020 12:17:48 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic cancers are rarely able to be cured, and treatment of bone metastasis involves medications to shrink, stop or slow down the growth of the tumor.

Treatment options available for bone metastasis are symptomatic treatments which are meant for pain control, treatment, and prevention of fractures, improvement in functional disability, etc. Randomized trials on metastatic patients by UBM Medica, LLC showed that 45-75% patients develop functional disability every 3-4 months, 10-15% patients develop hypercalcemia and 10-20% patients develop long bone fractures.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11731

Treatment of bone metastasis is the interdisciplinary field involving pain management, orthopedics, and other medical specialties. Primary factors driving the growth of bone metastasis therapeutics market are the global increase in cancer prevalence and delayed diagnosis of cancer in low-income countries.

According to University of Texas Southwestern Medical Center Dallas, over 600,000 of bone metastasis are diagnosed in the U.S. every year. Rapid innovation in the field of personalized medicine and identification of new therapeutic targets for bone metastasis presents a huge opportunity to manufacturers of targeted therapy agents.

A large number of treatment methods are still under investigation. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global bone metastasis therapeutics market.

The global market for bone metastasis therapeutics has been segmented on basis of treatment type, end user, and geography:

Based on treatment type, the global bone metastasis therapeutics market is segmented into following :

  • Drug Treatment
    • Pain Relievers
      • NSAIDs
      • opioids
    • Bone Building medications
      • corticosteroids
      • bisphosphonates
        • Teriparatide
        • Pamidronate
        • Medronate
    • Targeted Therapy Agents
  • Tumor Ablation Therapy
    • Radiofrequency ablation
    • Cryoablation
  • Surgery
  • Osteoplasty
  • Orthopedic Fixation

Based on end user, the global bone metastasis therapeutics market is segmented into following :

  • Hospitals
  • Cancer Rehabilitation Centers
  • Specialty Clinics
  • Ambulatory Surgical Centers

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11731  

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl